Author:
Lin Zian,Chen Siyu,Su Lixian,Liao Yuxue,Chen Hongbiao,Hu Zhiqing,Chen Zhuolin,Fang Yuan,Liang Xue,Chen Jianan,Luo Biyun,Wu Chuanan,Wang Zixin
Publisher
Springer Science and Business Media LLC
Reference83 articles.
1. World Health Organization. Human papillomavirus and cancer, https://www.who.int/news-room/fact-sheets/detail/human-papilloma-virus-and-cancer; 2024. Accessed 3 Jan 2024.
2. Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 2021;134(7):783–91. https://doi.org/10.1097/cm9.0000000000001474.
3. Wang H, Jiang Y, Wang Q, Lai Y, Holloway A. The status and challenges of HPV vaccine programme in China: an exploration of the related policy obstacles. BMJ Glob Health. 2023;8(8). https://doi.org/10.1136/bmjgh-2023-012554.
4. Lu Y, Li P, Luo G, Liu D, Zou H. Cancer attributable to human papillomavirus infection in China: burden and trends. Cancer. 2020;126(16):3719–32. https://doi.org/10.1002/cncr.32986.
5. Centers for Disease Control and Prevention. HPV vaccine safety and effectiveness, https://www.cdc.gov/vaccines/vpd/hpv/hcp/safety-effectiveness.html; 2023. Accessed 17 Oct 2023.